KCT0006134
Not yet recruiting
未知
Study of optimal immunochemistry method using antibodies of methionyl-tRNA synthetase 1 (MARS1) in the pancreatic cancer cell
Yonsei University Health System, Gangnam Severance Hospital0 sites50 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Yonsei University Health System, Gangnam Severance Hospital
- Enrollment
- 50
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with pancreatic cancer confirmed by imaging (CT, MRI, PET\-CT)
- •2\. Patients with pancreatic cancer diagnosed using cytology by endoscopic ultrasound
- •3\. Patients who underwent surgical treatment with pancreatic cancer
Exclusion Criteria
- •1\. Minors under the age of 19, vulnerable subjects such as illiteracy
- •2\. Excludes necrotic specimens
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Development of a new immunochemistry method using antibodies of proteins related pancreatic cancer in the pancreatic cancer cellNeoplasmsKCT0004515Yonsei University Health System, Gangnam Severance Hospital100
Recruiting
Not Applicable
Development of a new immunochemistry method using antibodies of proteins related bile duct cancer in the bile duct cancer cell; pilot studyNeoplasmsKCT0003285Yonsei University Health System, Gangnam Severance Hospital100
Recruiting
Not Applicable
Identification of neutralizing antibodies against severe or chronic infections of human beingDRKS00010169niversitätsklinikum Köln1,000
Active, not recruiting
Phase 1
CHEMOIMMUNE - A Phase II study evaluating the safety and efficay of monoclonal antibody (pembrolizumab) in combination with a low-dose cyclophosphamide treatment in metastatic breast cancer patients with low white cellsMetastatic breast cancerMedDRA version: 20.0 Level: LLT Classification code 10027475 Term: Metastatic breast cancer System Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-002736-33-FRCENTRE LEON BERARD36
Recruiting
Not Applicable
Evaluation of an immunochromatography-based rapid antigen test for ocular infectionsOcular herpesvirus infectionJPRN-UMIN000050932Oita University150